Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 3Breast Neoplasms 3Prostatic Neoplasms 2Neuroblastoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia 2Endometrial Neoplasms 2Congenital Abnormalities 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Pleuropulmonary blastoma 1Papillomavirus Infections 1Pain 1Neurofibrosarcoma 1Neoplasms 1Myeloproliferative Syndrome, Transient 1Meningioma 1Melanoma 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Liposarcoma 1Leukemia, Eosinophilic, Acute 1

Interventions

Cytarabine 14Daunorubicin 8Gemtuzumab 7sargramostim 5Gene Expression Profiling 5Flow Cytometry 5Filgrastim 5Mitoxantrone 4Idarubicin 4Etoposide 4Clofarabine 3Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Observation 2Immunologic Techniques 2DNA Methylation 2zosuquidar trihydrochloride 1valspodar 1fludarabine phosphate 1etoposide phosphate 1Topotecan 1Thiotepa 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Pharmacogenomic Testing 1Microarray Analysis 1Methotrexate 1Mass Spectrometry 1Granulocyte Colony-Stimulating Factor 1Electrophoresis, Polyacrylamide Gel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Erythroblastic, Acute × Observation × Clear all
NCT02085408 2024-12-13

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Eastern Cooperative Oncology Group

Phase 3 Completed
727 enrolled 13 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00085709 2015-09-30

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

SWOG Cancer Research Network

Phase 3 Completed
637 enrolled 7 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡